Clinical Trials Directory

Trials / Completed

CompletedNCT01040702

The Effect of Methylphenidate on Decision-making Ability of Attention Deficit Hyperactivity Disorder (ADHD) Adults

The Effect of Methylphenidate on Decision-making Ability of ADHD Adults

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
58 (actual)
Sponsor
Shalvata Mental Health Center · Academic / Other
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to assess the effect of Methylphenidate on cognitive performance and decision-making ability of ADHD adults, and to compare this effect to the effect on healthy control adults.

Detailed description

Two matched groups of adults - with and without ADHD diagnosis - will perform a battery of computerized tasks assessing sustained attention,working-memory,non-verbal IQ,and decision-making ability. In each group,half of the participants will perform the tasks after receiving a capsule containing methylphenidate (MPH), and the other half will perform the tasks after receiving placebo. Task performance measures will then be compared in order to assess the effect of MPH on these domains.

Conditions

Interventions

TypeNameDescription
DRUGmethylphenidatea single doses of 10-20 mg in each one of two visits
DIETARY_SUPPLEMENTsweetener pilla capsule containing a sweetener pill

Timeline

Start date
2008-01-01
Primary completion
2009-08-01
Completion
2009-12-01
First posted
2009-12-30
Last updated
2009-12-30

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01040702. Inclusion in this directory is not an endorsement.